Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Chugai Pharmaceuticals and Omron Collaborate to Enhance Automation in Drug Discovery Research
Tuesday, July 18, 2023Chugai Pharmaceutical and Omron Corporation have joined forces to automate research processes with the goal of enhancing the productivity of drug discovery research improving the quality of experimental data and enabling new experimental activities
Boehringer Ingelheim Launches New SGLT-2 Inhibitor Esgliteo
Tuesday, July 18, 2023Boehringer Ingelheim has launched Esgliteo empagliflozinlinagliptin a compound therapy of the SGLT inhibitor Jardiance empagliflozin and the DPP inhibitor Trajenta linagliptin
Antengene Receives Regulatory Approval for XPOVIO® in Hong Kong
Monday, July 17, 2023Antengene Corporation has received approval from the Government of the Hong Kong Special Administrative Region HKSAR for their New Drug Application NDA of XPOVIO selinexor in combination with dexamethasone Xd
InnoCare Pharma Collaborates with ArriVent Biopharma
Friday, July 14, 2023InnoCare Pharma and ArriVent Biopharma have entered into a clinical development collaboration to assess the combination of two investigational drugs ICP and furmonertinib for the treatment of advanced nonsmall cell lung cancer NSCLC
Chugai Pharmaceutical, OMRON, and OMRON SINIC X Collaborate on Testing Human-Friendly Lab Automation System
Friday, July 14, 2023Chugai Pharmaceutical OMRON Corporation and OMRON SINIC X Corporation are collaborating to automate research processes in drug discovery The verification testing of the system is being carried out at Chugais research centre Chugai Life Science Park Y...
Astellas' Marketing Authorisation Application for Zolbetuximab Accepted by the European Medicines Agency
Friday, July 14, 2023Astellas Pharma has announced that the European Medicines Agency EMA has accepted the marketing authorisation application MAA for zolbetuximab
InnoCare Pharma Collaborates with ArriVent Biopharma
Friday, July 14, 2023InnoCare Pharma and ArriVent Biopharma have entered into a clinical development collaboration to assess the combination of two investigational drugs ICP and furmonertinib for the treatment of advanced nonsmall cell lung cancer NSCLC
FDA Accepts BeiGene's Supplemental New Drug Application for BRUKINSA® (Zanubrutinib)
Thursday, July 13, 2023BeiGene has announced that the US Food and Drug Administration FDA has accepted the supplemental new drug application sNDA for BRUKINSA zanubrutinib in combination with obinutuzumab for the treatment of adult patients with relapsed or refractory foll...
LianBio Announces Clinical Supply Agreement with AstraZeneca in China
Thursday, July 13, 2023The agreement aims to evaluate the safety and efficacy of BBP an investigational SHP inhibitor developed by LianBio and BridgeBio in combination with AstraZenecas osimertinib an epidermal growth factor receptor EGFR inhibitor
Biosyngen Receives US FDA Fast Track Designation for BRG01
Wednesday, July 12, 2023Biosyngens BRG therapy has received Fast Track Designation FTD from the US Food and Drug Administration FDA for the treatment of relapsedmetastatic nasopharyngeal carcinoma
